BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30226563)

  • 1. Downregulation of glucose-regulated protein 78 enhances the cytotoxic effects of curcumin on human nasopharyngeal carcinoma cells.
    Yu X; Shi L; Yan L; Wang H; Wen Y; Zhang X
    Int J Mol Med; 2018 Nov; 42(5):2943-2951. PubMed ID: 30226563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel curcuminoid exhibits enhanced antitumor activity in nasopharyngeal carcinoma.
    Pan Y; Liu G; Xiao J; Su B; Zhou F; Wei Y
    Int J Oncol; 2016 May; 48(5):2175-83. PubMed ID: 26983360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new curcumin analogue exhibits enhanced antitumor activity in nasopharyngeal carcinoma.
    Pan Y; Xiao J; Liang G; Wang M; Wang D; Wang S; Yang H
    Oncol Rep; 2013 Jul; 30(1):239-45. PubMed ID: 23673810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of GRP78 enhances cell death by cisplatin and radiotherapy in nasopharyngeal cells.
    Huang YY; Pu LJ; Song LL; Ma LY; Liu H; Jiang CC
    Anticancer Drugs; 2016 Sep; 27(8):726-33. PubMed ID: 27254284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
    Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
    [No Abstract]   [Full Text] [Related]  

  • 6. The efficacy of cisplatin on nasopharyngeal carcinoma cells may be increased via the downregulation of fibroblast growth factor receptor 2.
    Pu L; Su L; Kang X
    Int J Mol Med; 2019 Jul; 44(1):57-66. PubMed ID: 31115494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin Inhibits Proliferation of Epstein-Barr Virus-Associated Human Nasopharyngeal Carcinoma Cells by Inhibiting EBV Nuclear Antigen 1 Expression.
    Liu L; Yang J; Ji W; Wang C
    Biomed Res Int; 2019; 2019():8592921. PubMed ID: 31687403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin exerts inhibitory effects on undifferentiated nasopharyngeal carcinoma by inhibiting the expression of miR-125a-5p.
    Gao W; Chan JY; Wong TS
    Clin Sci (Lond); 2014 Nov; 127(9):571-9. PubMed ID: 24896104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrandrine Induces Apoptosis of Human Nasopharyngeal Carcinoma NPC-TW 076 Cells through Reactive Oxygen Species Accompanied by an Endoplasmic Reticulum Stress Signaling Pathway.
    Lin YJ; Peng SF; Lin ML; Kuo CL; Lu KW; Liao CL; Ma YS; Chueh FS; Liu KC; Yu FS; Chung JG
    Molecules; 2016 Oct; 21(10):. PubMed ID: 27754332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin Increases Radiosensitivity of Radioresistant Nasopharyngeal Cancer.
    Wang G; Zhu J; Wang Z; Xu Z; Shi Y; Luo L
    Discov Med; 2023 Jun; 35(176):418-428. PubMed ID: 37272108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FM807, a curcumin analogue, shows potent antitumor effects in nasopharyngeal carcinoma cells by heat shock protein 90 inhibition.
    Ye M; Huang W; Wu WW; Liu Y; Ye SN; Xu JH
    Oncotarget; 2017 Feb; 8(9):15364-15376. PubMed ID: 28157708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin enhances the effects of irinotecan on colorectal cancer cells through the generation of reactive oxygen species and activation of the endoplasmic reticulum stress pathway.
    Huang YF; Zhu DJ; Chen XW; Chen QK; Luo ZT; Liu CC; Wang GX; Zhang WJ; Liao NZ
    Oncotarget; 2017 Jun; 8(25):40264-40275. PubMed ID: 28402965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin and wikstroflavone B, a new biflavonoid isolated from Wikstroemia indica, synergistically suppress the proliferation and metastasis of nasopharyngeal carcinoma cells via blocking FAK/STAT3 signaling pathway.
    Shao M; Lou D; Yang J; Lin M; Deng X; Fan Q
    Phytomedicine; 2020 Dec; 79():153341. PubMed ID: 32992086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid β precursor protein silencing attenuates epithelial‑mesenchymal transition of nasopharyngeal carcinoma cells via inhibition of the MAPK pathway.
    Xu J; Ying Y; Xiong G; Lai L; Wang Q; Yang Y
    Mol Med Rep; 2019 Jul; 20(1):409-416. PubMed ID: 31180550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eudesmin exerts antitumor effects by down-regulating EZH2 expression in nasopharyngeal carcinoma cells.
    Yu M; Li Y; Li M; Lu D
    Chem Biol Interact; 2019 Jul; 307():51-57. PubMed ID: 31026422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal ERp44 derived from ER-stressed cells strengthens cisplatin resistance of nasopharyngeal carcinoma.
    Xia T; Tian H; Zhang K; Zhang S; Chen W; Shi S; You Y
    BMC Cancer; 2021 Sep; 21(1):1003. PubMed ID: 34493236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHM-1 Suppresses Formation of Cell Surface-associated GRP78-p85α Complexes, Inhibiting PI3K-AKT Signaling and Inducing Apoptosis of Human Nasopharyngeal Carcinoma Cells.
    Lin ML; Chen SS; Ng SH
    Anticancer Res; 2015 Oct; 35(10):5359-68. PubMed ID: 26408697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin analogue T83 exhibits potent antitumor activity and induces radiosensitivity through inactivation of Jab1 in nasopharyngeal carcinoma.
    Pan Y; Wang M; Bu X; Zuo Y; Wang S; Wang D; Liu Q; Su B; Xu T; Wang C; Claret FX; Yang H
    BMC Cancer; 2013 Jul; 13():323. PubMed ID: 23815987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the MEK/ERK Pathway Mediates the Inhibitory Effects of Silvestrol on Nasopharyngeal Carcinoma Cells via RAP1A, HK2, and GADD45A.
    Yu LR; Han XZ; Tang YZ; Liu D; Luo XQ; Qiu XW; Feng J; Yuan WX; Ding JY
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):160. PubMed ID: 38682208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular signal-regulated kinase signaling-mediated induction and interaction of FOXO3a and p53 contribute to the inhibition of nasopharyngeal carcinoma cell growth by curcumin.
    Wu J; Tang Q; Zhao S; Zheng F; Wu Y; Tang G; Hahn SS
    Int J Oncol; 2014 Jul; 45(1):95-103. PubMed ID: 24806432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.